well one does feel like a captive audience..Its back to the...

well one does feel like a captive audience..
Its back to the liquidity problems, of the share trading depth and the company cash flow,
For what its worth heres a little TA compensation ...with the 50 retrace target that was met..

last Nov
" Upon placement of the remaining shortfall shares, the Company will have sufficient working capital to
complete its 150-patient phase IIa clinical trial in Rheumatoid Arthritis. The Company recently announced it
had completed recruitment of patients into the trial, with final study reports from the trial expected to be
received in Q2 2011."

Always going to cut it fine ,but now in preopen to announce new raising details?
Surely we will sniff some results before that.

Sorry just a little rave..I obviously dont do fundamentals to well....lol